Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
EMBO Mol Med
JSON
ISSN
1757-4684
ISSN-L
1757-4676
IUID
31de0e64e99646c8bd5bcfd774900235
Modified
2020-11-27T13:12:56.959Z
Created
2018-12-05T08:57:43.844Z
Year 2026
PubMed
DOI
Crossref
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.
Farini A
,
Tripodi L
, Villa C, ..., Quattrocelli M,
Torrente Y
EMBO Mol Med
18
(7) 2979-3008 [2026-07-00; online 2026-06-03]
Year 2024
PubMed
DOI
Crossref
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations.
Pham VC
,
Rödel CJ
,
Valentino M
, ...,
Pagani M
,
Abdelilah-Seyfried S
EMBO Mol Med
16
(11) 2827-2855 [2024-11-00; online 2024-10-14]
PubMed
DOI
Crossref
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment.
Hunt M
, Wang N, Pupinyo N, ...,
Bachar-Wikstrom E
,
Wikstrom JD
EMBO Mol Med
16
(9) 1986-2001 [2024-09-00; online 2024-07-26]
Year 2023
PubMed
DOI
Crossref
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
Farini A,
Tripodi L
, Villa C, ..., Quattrocelli M,
Torrente Y
EMBO Mol Med
15
(3) e16244 [2023-03-08; online 2022-12-19]
Year 2022
PubMed
DOI
Crossref
Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells.
Sanchez-Burgos L
,
Navarro-González B
,
García-Martín S
, ..., Al-Shahrour F,
Fernandez-Capetillo O
EMBO Mol Med
14
(9) e15855 [2022-09-07; online 2022-07-21]
Year 2020
PubMed
DOI
Crossref
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
Rudd SG
, Tsesmetzis N, Sanjiv K, ...,
Helleday T
,
Herold N
EMBO Mol Med
12
(3) e10419 [2020-03-06; online 2020-01-17]
Year 2019
PubMed
DOI
Crossref
What is normal? Apelin and VEGFA, drivers of tumor vessel abnormality.
Claesson-Welsh L
EMBO Mol Med
11
(8) e10892 [2019-08-00; online 2019-07-18]
PubMed
DOI
Crossref
Targeting miR-34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia.
Ruiz-Camp J, Quantius J, Lignelli E, ..., Seeger W,
Morty RE
EMBO Mol Med
11
(3) - [2019-03-00; online 2019-02-17]
Year 2018
PubMed
DOI
Crossref
Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.
Kondelin J, Salokas K, Saarinen L, ...,
Pitkänen E
,
Aaltonen LA
EMBO Mol Med
10
(9) - [2018-09-00; online 2018-08-16]
Year 2016
PubMed
DOI
Crossref
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
Jin C, Fotaki G, Ramachandran M, ...,
Essand M
, Yu D
EMBO Mol Med
8
(7) 702-711 [2016-07-00; online 2016-07-01]
Year 2014
PubMed
DOI
Crossref
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.
Ayoglu B, Chaouch A, Lochmüller H, ..., Nilsson P, Al-Khalili Szigyarto C
EMBO Mol Med
6
(7) 918-936 [2014-07-00; online 2014-06-13]
SciLifeLab Data Centre
Publications
9.5.1